Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study

Vaccination constitutes the best long-term solution against Coronavirus Disease-2019; however, vaccine-derived immunity may not protect all groups equally, and the durability of protective antibodies may be short. We evaluate Spike-antibody responses following BNT162b2 or ChAdOx1-S vaccination among...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrotri, Madhumita, Fragaszy, Ellen, Nguyen, Vincent, Navaratnam, Annalan M. D., Geismar, Cyril, Beale, Sarah, Kovar, Jana, Byrne, Thomas E., Fong, Wing Lam Erica, Patel, Parth, Aryee, Anna, Braithwaite, Isobel, Johnson, Anne M., Rodger, Alison, Hayward, Andrew C., Aldridge, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526787/
https://www.ncbi.nlm.nih.gov/pubmed/36184633
http://dx.doi.org/10.1038/s41467-022-33550-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526787/
https://www.ncbi.nlm.nih.gov/pubmed/36184633
http://dx.doi.org/10.1038/s41467-022-33550-z

Ejemplares similares